Correlation Between Institute and Defence Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Institute and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Institute and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Institute of Biomedical and Defence Therapeutics, you can compare the effects of market volatilities on Institute and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Institute with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Institute and Defence Therapeutics.

Diversification Opportunities for Institute and Defence Therapeutics

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Institute and Defence is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Institute of Biomedical and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Institute of Biomedical are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Institute i.e., Institute and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Institute and Defence Therapeutics

Given the investment horizon of 90 days Institute of Biomedical is expected to generate 1.43 times more return on investment than Defence Therapeutics. However, Institute is 1.43 times more volatile than Defence Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Defence Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  1.20  in Institute of Biomedical on September 3, 2024 and sell it today you would lose (0.25) from holding Institute of Biomedical or give up 20.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.79%
ValuesDaily Returns

Institute of Biomedical  vs.  Defence Therapeutics

 Performance 
       Timeline  
Institute of Biomedical 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.
Defence Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Defence Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Institute and Defence Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Institute and Defence Therapeutics

The main advantage of trading using opposite Institute and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Institute position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.
The idea behind Institute of Biomedical and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities